B. D. Agnis, D. S. Berman, D. Spicehandler, W. El-sadr, M. S. Simberkoff et al., Effect of Combined Therapy with Ansamycin, Clofazimine, Ethambutol, and Isoniazid for Mycobacterium avium Infection in Patients with AIDS, Journal of Infectious Diseases, vol.159, issue.4, pp.784-787, 1989.
DOI : 10.1093/infdis/159.4.784

E. J. Baron and L. S. Young, Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome, Diagnostic Microbiology and Infectious Disease, vol.5, issue.3, pp.215-220, 1986.
DOI : 10.1016/0732-8893(86)90004-0

G. Canetti, S. Froman, J. Grosset, P. Hauduroy, M. Langerova et al., Mycobacteria: laboratory methods for testing drug sensitivity and resistance, Bull. W. H. O, vol.29, pp.565-578, 1963.

J. Chiu, J. Nussbaum, S. Bozettz, J. G. Tilles, L. S. Young et al., Treatment of Disseminated Mycobacterium avium Complex Infection in AIDS with Amikacin, Ethambutol, Rifampin, and Ciprofloxacin, Annals of Internal Medicine, vol.113, issue.5, pp.358-361
DOI : 10.7326/0003-4819-113-5-358

H. L. David, Basis for Lack of Drug Susceptibility of Atypical Mycobacteria, Clinical Infectious Diseases, vol.3, issue.5, pp.878-884, 1981.
DOI : 10.1093/clinids/3.5.878

L. Heifets, P. Lindholm-levy, J. Libonati, N. Hooper, A. Laszlo et al., Radiometric broth macrodilution method for determination of MICs with Mycobacterium avium complex isolates, National Jewish Center for Immunology and Respiratory Medicine, 1993.

L. B. Heifets, MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs., Antimicrobial Agents and Chemotherapy, vol.32, issue.8, pp.1131-1136, 1988.
DOI : 10.1128/AAC.32.8.1131

L. B. Heifets, Dilemmas and realities in drug susceptibility testing of Mycobacterium avium-intracellulare and other slowly growing nontuberculous mycobacteria Drug susceptibility in the chemotherapy of mycobacterial infections, pp.123-141, 1991.

S. E. Hoffner, G. Källenius, A. E. Beezer, and S. B. Svenson, Studies on the mechanisms of synergistic effects of ethambutol and other antimycobacterial drugs on Mycobacterium avium complex, Acta Leprol, vol.7, pp.195-199, 1989.

S. E. Hoffner, S. B. Svenson, and G. Källenius, Synergistic effects of antimycobacterial drag combinations onMycobacterium avium complex determined radiometrically in liquid medium, European Journal of Clinical Microbiology, vol.129, issue.5, pp.530-535, 1987.
DOI : 10.1007/BF02014241

J. Hoy, A. Mijch, M. Sandland, L. Grayson, R. Lucas et al., Quadruple-Drug Therapy for Mycobacterium avium-intracellulare Bacteremia in AIDS Patients, Journal of Infectious Diseases, vol.161, issue.4, pp.801-805, 1990.
DOI : 10.1093/infdis/161.4.801

C. B. Inderlied, F. G. Sandoval, and L. S. Young, In vitro activity of clarithromycin (CLARI) and 14-hydroxy-clarithromycin against the Mycobacterium avium complex (MAC) alone and in combination with other agents, abstr. 239, p. 138, Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, 1991.

B. Ji, N. Lounis, C. Truffot-pernot, and J. H. Grosset, In vitro activities of clarithromycin-containing double-or triple-drug combinations against Mycobacterium avium complex, abstr. 155, Abstracts of the 1st International Conference on Macrolides, 1992.

J. K. Mcclatchy, Antituberculous drugs: mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids Antibiotics in laboratory medicine, pp.135-169, 1980.

D. S. Prince, D. D. Peterson, R. M. Steiner, J. E. Gottlieb, R. Scott et al., Complex in Patients without Predisposing Conditions, New England Journal of Medicine, vol.321, issue.13, pp.863-868, 1989.
DOI : 10.1056/NEJM198909283211304

N. Rastogi, Mycobacteria as intracellular pathogens: current notions of pathogenicity, virulence, and drug resistance and their relation to effective therapy Antimicrobial agents and intracellular pathogens, pp.245-300, 1993.

N. Rastogi, W. W. Barrow, J. O. Falkinham, I. , C. O. Thoen et al., Laboratory and clinical aspects of the Mycobacterium avium epidemic: Contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicity, Research in Microbiology, vol.145, issue.3, pp.167-261, 1994.
DOI : 10.1016/0923-2508(94)90012-4

URL : https://hal.archives-ouvertes.fr/pasteur-00925368

N. Rastogi, C. Fréhel, A. Ryter, H. Ohayon, M. Lesourd et al., Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?, Antimicrobial Agents and Chemotherapy, vol.20, issue.5, pp.666-677, 1981.
DOI : 10.1128/AAC.20.5.666

N. Rastogi, K. S. Goh, and H. L. David, Drug susceptibility testing in tuberculosis: A comparison of the proportion methods using Lowenstein-Jensen, middlebrook 7H10 and 7H11 agar media and a radiometric method, Research in Microbiology, vol.140, issue.5, pp.405-417, 1989.
DOI : 10.1016/0923-2508(89)90016-8

N. Rastogi, K. S. Goh, and H. L. David, Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis., Antimicrobial Agents and Chemotherapy, vol.34, issue.5, pp.759-764, 1990.
DOI : 10.1128/AAC.34.5.759

N. Rastogi, K. S. Goh, N. Guillou, and V. Labrousse, Spectrum of drugs against atypical mycobacteria: How valid is the current practice of drug susceptibility testing and the choice of drugs?, Zentralblatt f??r Bakteriologie, vol.277, issue.4, pp.474-484, 1992.
DOI : 10.1016/S0934-8840(11)80472-X

N. Rastogi, A. Kochi, B. Vareldzis, K. Styblo, J. T. Crawford et al., Emergence of multiple-drug-resistant tuberculosis: fundamental and applied research aspects, global issues and current strategies, Research in Microbiology, vol.144, issue.2, pp.103-158, 1993.
DOI : 10.1016/0923-2508(93)90022-T

N. Rastogi and V. Labrousse, Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex., Antimicrobial Agents and Chemotherapy, vol.35, issue.3, pp.462-470, 1991.
DOI : 10.1128/AAC.35.3.462

N. Rastogi, V. Labrousse, J. P. Carvalho, and . Sousa, Ethambutol FIG. 5. Graphic representation of MIC 50 s and MIC 90 s of the 10 antibiotics for MAC clinical isolates. The graph is based on the modal MICs determined by multiple testing. D-CS, D-cycloserine; EMB, ethambutol, 1993.

N. Rastogi, V. Labrousse, K. S. Goh, J. P. Carvalho, and . Sousa, Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages., Antimicrobial Agents and Chemotherapy, vol.35, issue.12, pp.2473-2480, 1991.
DOI : 10.1128/AAC.35.12.2473

S. H. Siddiqi, J. E. Hawkins, and A. Laszlo, Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by radiometric and conventional methods, J. Clin. Microbiol, vol.22, pp.919-923, 1985.

S. H. Siddiqi, L. B. Heifets, M. H. Cynamon, N. M. Hooper, A. Laszlo et al., Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates, J. Clin. Microbiol, vol.31, pp.2332-2338, 1993.

S. H. Siddiqi, J. P. Libonati, and G. Middlebrook, Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis, J. Clin. Microbiol, vol.13, pp.908-912, 1981.

F. Stauffer, O. Dörtbudak, and E. Lahonik, Wirksamkeit von Clarithromycin in Kombination mit Ethambutol und Rifampicin gegen Mycobacterium avium-Komplex basierend auf Invitro-Untersuchungen, Infection, vol.68, issue.5, pp.343-345, 1991.
DOI : 10.1007/BF01645362

D. M. Yajko, In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?, Research in Microbiology, vol.143, issue.4, pp.411-419, 1992.
DOI : 10.1016/0923-2508(92)90055-S